Back to Publications
February, 2019

Press Release - Viedoc

Blueclinical Expands Business with Viedoc to Accelerate Bioequivalence and Early-Stage Clinical Studies

https://www.viedoc.com/viedoc-news/blueclinical-expands-business-with-viedoc-to-accelerate-bioequivalence-and-early-stage-clinical-studies/

Other Publication


Clinical Trial - Alzheimer's Disease

ULSM (Unidade Local de Saúde de Matosinhos) is currently conducting an Alzheimer's Disease Clinical Trial. For more informations, please contact: crpulsm@blueclinical.pt | 910 016 380

Blueclinical has been accredited by the French authorities to Crédit Impôt Recherche.

We are pleased to announce that Blueclinical has been accredited by the French authorities to Crédit Impôt Recherche. As such, French companies carrying out research activities with Blueclinical have a significant competitive advantage: tax credit of 30% of the value of the investment made.